1. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG);Chen;Vaccine,2015
2. WHO informal consultation on characterization and quality aspect of vaccines based on live viral vectors;World Health Organization,2003
3. WHO informal consultation: development of viral vectored vaccines for HIV, malaria, tuberculosis and other indications;World Health Organization,2013
4. Guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines;European Medicines Agency,2010
5. Determining the need for and content of environmental assessments for gene therapies, vectored vaccines, and related recombinant viral or microbial products; guidance for industry;U.S. Food and Drug Administration,2015